The latest news from The VIVA Foundation
Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.
News & Updates
Dr. Kush R. Desai Appointed to The VIVA Foundation Board of Directors
December 18, 2024The VIVA Foundation has appointed Kush R. Desai, MD, FSIR, as the newest member of the Board of Directors. The Foundation is a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education, research, advocacy, and collaboration. Dr. Desai has collaborated with The ...
News & Updates
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
November 5, 2024The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVentional Advanc ...
News & Updates
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
November 5, 2024The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVention ...
News & Updates
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
November 4, 2024The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVentio ...
News & Updates
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
November 4, 2024The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVention ...